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1. SUMMARY 
In this thesis (TFG) the results of the comparison of three assays 
for the measurement of AhR ligand activity are exposed. This study was 
part of a collaborative project aiming at the characterization of the AhR 
signaling activities of known naturally occurring compounds to explore 
the potential of using non-toxic compounds to treat inflammatory 
diseases via oral administration.  
 
The first goal of this project was to find an assay able to measure 
AhR-activity, so the comparison of different assays has been done in 
order to find the most convenient one according to the efficiency, 
sensitivity and precision. Moreover, other elements with operational 
nature such as price, toxicity of components or ease of use has been 
considered. From the use of compounds known from the literature to be 
AhR ligands, three assays have been tested: (1) P450-GloTM CYP1A2 
Induction/Inhibition assay, (2) quantitative Polymerase Chain Reaction 
(qPCR) and (3) DR. CALUX® Bioassay. Moreover, a different experiment 
using the last assay was performed for the study in vivo of the transport 
of the compounds tested.  
 
The results of the TFG suggested the DR. CALUX® Bioassay as 
the most promising assay to be used for the screening of samples as 
AhR-ligands because it is quicker, easier to handle and less expensive 
than qPCR and more reproducible than the CYP1A2 Induction/Inhibition 
assay. Moreover, the use of this assay allowed having a first idea of 
which compounds are uptaken by the epithelial barrier and in with 
direction the transport happens. 
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2. INTRODUCTION 
2.1. Definition 
Aryl hydrocarbon receptor (AhR) is a ligand-activated cytosolic 
transcription factor initially known for its role in the regulation of dioxin toxicity, 
as it recognizes numerous small xenobiotics and natural molecules and 
regulate some metabolizing enzymes that detoxify them. Recent findings has 
brought AhR into mainstream research on mucosal immunology and intestinal 
health research as it provides a molecular pathway by which endogenous and 
environmental signals can influence the immune response. Thus, AhR is seen 
as a possible target for therapeutic intervention in immune-mediated disorders 
1. Moreover, there is recent data from animal models that has demonstrated the 
possibility of targeting the AhR to treat inflammatory and autoimmune diseases 
2, 3. 
One of these studies had focused on the role of natural plant derived 
dietary compounds found in the conventional rodent diet as agonists of AhR. 
The replacement of this conventional mouse diet containing plant AhR agonists 
with a synthetic highly refined diet devoid of plant products have an impact on 
the intestinal homeostasis4 (Figure 1).  
 
The picture in Figure 1A shows how a balanced diet maintains intestinal 
mucosal homeostasis by many mechanisms. The most important is the role of 
intraepithelial lymphocytes (IELs) as they support epithelial cell growth and 
have a role in immune surveillance. IELs are involved in stimulating epithelial 
cell turnover in the small intestine, thereby maintaining the intestinal villi and 
providing protection against mechanical or microorganism-induced damage. 
Moreover, IELs are essential mediators of host-microorganism homeostasis, as 
they can directly lyse target cells through the expression of granzymes and 
perforin and secrete antimicrobial factors 5. 
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Decrease in the number of IELs when a diet is low in AhR ligands alters 
intestinal homeostasis (Figure 1B). Thus, decrease or absence in the number of 
IELs reduces the ability of the intestine to repair tissue damage. Therefore, the 
epithelial barrier is compromised and immunity is reduced, increasing the risk of 
bacterial dissemination into the lamina propria, leaving to microbial infection and 
tissue damage so finally resulting in an overt inflammatory response. 
The addition of synthetic ligands for AhR into the synthetic diet restored 
normal numbers of these IELs, highlighting the importance of dietary 
components rich in AhR ligands, especially early in life for the maintenance of 
immune populations within the gut mucosa.   
 
 
 
2.2. AhR signaling pathway  
AhR is a ligand-activated member of the Per-Arnt-Sim family of basic 
helix–loop–helix transcription factors. Normally, AhR forms cytoplasmic 
complexes with various proteins, such as heat shock protein 90, AhR-
interacting protein, chaperones and p23. Binding of AhR to ligands, such as 
TCDD, induces translocation of the Ahr complex into the nucleus, where ligand-
bound AhR complex dissociates from chaperone proteins after dimerization with 
AhR nuclear translocator (Arnt).  
Figure 1.  Role of AhR in maintainance of the intestinal homeostasis 
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In the nucleus, AhR–Arnt heterodimers bind xenobiotic-responsive 
elements (DREs/XREs) in the promoters of responsive genes, thereby inducing 
AhR-dependent gene expression, including those encoding members of the 
cytochrome P450 (CYP) family 6 (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3. AhR ligands 
The diet, particularly vegetables, fruits and teas 7,8, is an important 
source of AhR ligands, mostly flavonoids and other phytochemicals such as 
quercetin, curcumin, resveratrol, and tryptophan metabolites as DIM (3-3 
diindolylmethane) and L-kynurenine. These natural compounds have been 
shown to be less toxic but still able to elicit responses through the AhR pathway 
9.  
Figure 2. AhR signaling pathway. (a) Ligand passes through plasma membrane into the 
cellular cytoplasm. (b) Ligand binds to  cytosolic AhR complex. (c) The ligand-bound 
AhR complex is translocated into the nucleus. (d) The ligand-bound AhR complex 
dissociates from chaperone proteins after dimerization with ARNT. (e) Ligand-bound 
AhR/ARNT complex binds to DREs/XREs, (f) which leads to transcriptional activation of 
target genes. 
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Quercetin is one of the most abundant polyphenolic compounds in the 
human diet 10 and can be found in numerous vegetables, fruits, seeds and nuts, 
as well as in tea and red wine 11 and it has been shown to elicit anti-
inflammatory properties 12, 13, 14, 15, 16.  
Curcumin is a lipophilic polyphenol found in the rhizome of the plant 
Curcuma longa 17, used in the traditional Indian medicine to treat a number of 
ailments like anorexia, inflammation, wound healing, arthritis, and sinusitis 18 
and it has been shown to exert antioxidant, antiproliferative, antiangiogenic, 
apoptotic, and anticancer properties, supporting its use in traditional Indian 
medicine and to protect many tissue types, such as brain, heart, liver, lungs, 
kidneys and skin, from oxidative agents 19. 
Resveratrol is a naturally occurring nonflavonoid polyphenol that can be 
found in a variety of dietary sources, including grape seeds, peanuts, and 
mulberries 20. Plants produce resveratrol as a stress response against invading 
fungus, which highlights the natural antifungal properties of this compound 21. It 
is an important component of the root of Polygonum cuspidatum, also known as 
ko-jo-kon, which is used in Eastern medicine to treat diseases of the blood 
vessels, heart, and liver 21-28. Resveratrol has also been suggested to have 
possible therapeutic applications in numerous areas due to its cardioprotective 
28, 29, anticancer 30, antioxidant 31, cholesterol-lowering 32 and antiaging effects 
33. 
Resveratrol is also able to downregulate various proinflammatory 
cytokines and the number of Th17 cells, supporting the potential usefulness in 
inflammatory conditions 9.  
DIM is an indole compound, a by-product of I3C (indole-3-carbinol) after 
the acid hydrolysis during digestion within the gut 34. Recent studies have 
indicated that this compound may play a critical role in modulating immune 
responses, particularly with regards to inflammation and inflammatory diseases 
35, 36. 
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Finally, L-Kynurenine is a metabolite of the amino acid L-tryptophan, 
synthesized by the enzyme tryptophan dioxygenase, which is made primarily 
but not exclusively in the liver, and indoleamine 2,3-dioxygenase, which is made 
in many tissues in response to immune activation. L-Kynurenine and its further 
breakdown products carry out diverse biological functions, including dilating 
blood vessels during inflammation and regulating the immune response 37. 
 
In this study previous known AhR-ligand compounds were used to 
optimize different assays for the screening of potential AhR-ligands. 
 
2.4. AhR Assays 
In order to investigate the effect of different natural occurring compounds 
on the activation of the AhR pathway, three previous steps have to be done. 
First, the comparison of different assays able to measure AhR- activity is 
needed to find the most convenient one according to the efficiency, sensitivity 
and precision. Moreover, other elements with operational nature such as price, 
toxicity of components or ease of use should also be considered. Second, the 
optimization of the chosen assay to characterize AhR ligands has to be done 
and finally, by using the optimized assay, a third step will allow the screening of 
samples as possible ligands.  
In this study the first step was developed and three different assays were 
used to check which one meets most of the conditions listed above.  
  
P450-GloTM CYP1A2 Induction/Inhibition assay is based on the power of 
CYP enzymes to catalyze a reaction that converts a luminogenic substrate 
(proluciferin) to luciferin. Luciferin can be detected with the Luciferin Detection 
reagent 38. With this assay the amount of CYP1A2 produced in cells as a 
consequence of AhR activation can be quantified as it is proportional to the light 
output of the luciferase reaction (Figure 3).   
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A quantitative polymerase chain reaction (qPCR), also called real-time 
polymerase chain reaction, is a molecular biology technique used to amplify and 
simultaneously quantify a targeted DNA molecule, in this case CYP1A1 gene. 
The quantity can be either an absolute number of copies or a relative amount 
when normalized to DNA input or additional normalizing. Relative quantification 
is the most used and it calculates the ratio between a housekeeping gene, a 
gene which is constitutive expressed (in this case GAPDH), and the gene of 
interest (CYP1A1). Thus, by dividing the signal of the gene of interest by the 
signal of the normalized gene it is possible to compare the results without 
knowing their absolute level of expression. 
QPCR is carried out in a thermal cycler with the capacity to illuminate 
each sample with a beam of light of a specified wavelength and detect the 
fluorescence emitted by the excited fluorophore. The qPCR process generally 
consists of a series of temperature changes that are repeated 25 – 40 times, 
which normally consist of a first step, at around 95 °C, which allows the 
separation of the nucleic acid double chain and a second one, at a temperature 
of around 50-60 °C, that allows the binding of the primers with the DNA 
template. In addition, some thermal cyclers add another short temperature 
Figure 3. Luciferase reaction. 
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phase lasting only a few seconds to each cycle, called melting curve, in order to 
reduce the noise caused by the presence of primer dimers when a non-specific 
dye is used.  
The qPCR technique used in this study uses a non-specific fluorochrome 
(SYBR-Green), a fluorescent dye that intercalate with any double-stranded 
DNA. Thus, while exiting the sample using blue light (λmax = 488 nm) it emits 
green light (λmax = 522 nm), which can be detected. This method has the 
advantage of only needing a pair of primers to carry out the amplification, which 
keeps costs down. However, it is only possible to amplify one product in each 
reaction. 
 
The Dioxin Receptor Chemical-Activated LUciferase gene eXpression 
assay (DR. CALUX® Bioassay) was developed for the detection of dioxins in 
samples and is based on the principle that dioxins can activate AhR pathway for 
the translation of detoxifying enzymes 39, 40, 41. 
This assay is a receptor based reporter gene assay which utilizes Rat 
H4IIE hepatoma cells, stably transfected with an AhR-controlled luciferase 
reporter gene construct, so in response to compounds that stimulate AhR 
pathway, particularly the binding of AhR-ligand complex to DRE element, this 
cell-line will synthesize luciferase in a dose-dependent way 42, which can 
subsequently be quantified by an enzymatic light producing reaction (Figure 4). 
. 
 
 
 
 
 
 
Figure 4. Schematic representation of the mechanism of action of the DR-CALUX®. 
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In all assays TCDD has been used as a positive control as it gives strong 
signals, but the screening of different compounds may allow the detection of a 
less toxic substitute for TCDD. 
As the aim of this study was the comparison of different assays to check 
which one is more useful in an overall for the detection of AhR-activity, assays 
based on the measurement of different components in the AhR pathway were 
chosen. P450-GloTM CYP1A2 Induction/Inhibition assay detects the activity of 
CYP1A2 gene, qPCR the expression of CYP1A1 gene and DR. CALUX® 
Bioassay the activity of the transcription factors which activates the cellular 
detoxifying system. The first two assays focus on different genes transcribed 
after the binding of the AhR complex to the transcription factor and the third one 
on the binding itself.     
 
2.5. Intestinal uptake of Ahr-ligand compounds 
The first step for the study of transport, secretion and absorption of the 
ligands by the intestine is to simulate the gut epithelial barrier. This is possible 
by using a transwell system, which produces a cell culture environment that 
closely resembles the in-vivo state and enables growth of specialized cell types, 
in particular polarized intestinal epithelial cells (Figure 5). 
By stimulating the apical or the basolateral compartments with different 
compounds, transwell system allows the study of the uptake of those 
compounds in the gut, from the luminal to the serosal side or the other way 
around. 
 
 
 
 
 
Figure 5. Transwell system. 
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3. OBJECTIVES 
 
3.1. General objective 
This work is part of a collaborative project aiming at the characterization 
of the AhR signaling activities of known naturally occurring compounds to 
explore the potential of using non-toxic compounds to treat inflammatory 
diseases via oral administration. 
 
3.2. Specific objectives 
1) Comparison of the currently available assays for measurement of AhR 
–ligand activity: 
 CYP1A2 Assay  
 qPCR   
 DR-CALUX Bioassay  
2) Study of the transport, secretion and ligand absorption using polarized 
CaCo2 monolayers grown in transwell filter inserts, in order to understand the 
mechanisms by which compounds reach the lumen. 
3) Look for a non-toxic substitute of TCDD as a positive control for all the 
assays tested. 
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4. MATERIALS AND METHODS 
For the selection of an assay for the screening of samples as AhR 
ligands, compounds known from literature that act as AhR-ligands and the right 
concentrations of them were used to compare different parameters of each 
assay. Before the performance of each assay, HepG2 cells for the CYP1A2 
Induction/Inhibition assay and QPCR and CALUX cells for DR. CALUX 
Bioassay were stimulated with the compounds for 24 hours in order to let them 
go into the cells and bind to the AhR, so activate the AhR pathway. HepG2 
were selected for the stimulation because even though they are not intestinal 
cells it is known from literature that they are the most used in these studies.   
 
Once the assay that met more requirements was chosen, an in vitro 
study of the transport of the compounds was performed. Caco-2 cells, an 
intestinal cell line, was used to try to mimic the real behavior of the intestine, as 
they can be grown in a transwell system to reproduce the gut epithelial layer. In 
order to know if the compounds go either through or in between the cells in the 
monolayer (from the apical or luminal side to the serosal or basolateral side or 
vice versa) once the cells were stimulated either in the apical or basolateral 
compartment for 24 hours the supernatants of both sides were tested with the 
DR. CALUX Bioassay.  As it is known that this compounds are AhR-ligands, if 
they are present in the supernatants this assay will detect them. Thus, this 
assay permits to know in which compartment there is compound and quantify it. 
 
4.1. Cell lines 
HepG2 (DSMZ-ACC180) cells, derived from a well-differentiated 
hepatocellular carcinoma from human liver tissue, were obtained from DSMZ, 
Germany. Cells were cultured at 37ºC in 5% CO2 atmosphere in RPMI medium 
(Gibco, USA) supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) (Sigma-Aldrich, Germany) and 1% penicillin/streptomycin (P/S) (Sigma-
Aldrich). 
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The Caco-2 cell line, derived from heterogeneous human epithelial 
colorectal adenocarcinoma cells, was obtained from ATCC (LGC Standards 
GmbH, Germany) and cultured in Dulbecco’s Modified Eagle Medium (DMEM; 
Gibco) supplemented with 10% heat-inactivated FBS and 1% P/S.  
The CALUX cell line, which is derived from Rat H4IIE hepatoma cells and 
stably transfected with an AhR-controlled luciferase reporter gene construct, 
(pGudLuc1.1) was obtained from BioDetection Systems (Amsterdam, The 
Netherlands) and cultured in α-MEM medium (Gibco) supplemented with 10% 
heat-inactivated FBS and 0.6% P/S. 
 
4.2. Culture conditions 
HepG2 cells were seeded at a concentration of 3·105 cells/ mL in 48 and 
96-well plates and incubated to allow cell adherence. After 24 hours the cells 
were stimulated with different compounds and incubated overnight before the 
analysis. 
Caco-2 cells were seeded on filters at a concentration of 2·104 cells/ mL 
in 48 well plates and incubated for 2 weeks to allow monolayer and tight 
junction formation. Medium was refreshed every other day. Stimulation with 
different compounds was done 24 hours before the analysis. 
 
4.3. AhR-ligand compounds 
TCDD (SUPELCO) and DIM (3-3 diindolylmethane) were dissolved in 
DMSO, β-Naphthoflavone in CHCl3, α-Naphthoflavone in CH3OH, L-Kynuririne 
in 0.5M HCl, Quercetin in 1M NaOH and Resveratrol and Curcumin in EtOH (all 
Sigma-Aldrich, Germany) before their use. 
 
4.4. CYP1A2 Assay 
HepG2 cells43 were stimulated with the following compounds; 10nM 
TCDD, 6nM DIM, 100µM curcumin, 1mM L-kynurinine, 100µM β-
naphtophlavone, 100µM quercetin and 100µM resveratrol.  After 24 hours 
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incubation cells were washed twice with PBS before adding 50 µL luciferin/well. 
After 45 minutes incubation, 50 µL detection reagent was added in each well 
(P450-GloTM CYP1A2 Induction/Inhibition assay, Promega, Madison, WI, 
USA). Plates were shaken briefly prior to measurement. Luminescence was 
measured after 10 minutes in a Spectramax M5 (Molecular devices, CA, USA).  
 
4.5. RNA isolation, cDNA synthesis and qPCR 
Total RNA was isolated using RNeasy kit (Quiagen, Venlo, the 
Netherlands), with a DNase digestion step according to the manufacturer’s 
protocol. One µg was reverse transcribed using qScript cDNA synthesis kit 
(Quanta Biosciences, Gaithersburg, MD, USA) according to the manufacturer’s 
protocol. 
For qPCR 5µL cDNA (1:20 diluted from cDNA synthesis mixture) was 
used, together with 300nM forward and reverse primers (qPCR Primers for 
Human CYP1A1: PPH01271F from SABiosciences and the forward primer: 
“TGCACCACCAACTGCTTAGC” and reverse primer: 
“GGCATGGACTGTGGTCATGAG” for GAPDH gene), 6.25µL 2X Rotor-Gene 
SYBR Green PCR kit (Qiagen), and demineralized water up to a total volume of 
12.5 µL. QPCR was performed (5 min 95ºC, then 40 cycles of 5 sec at 95ºC, 10 
sec at 60ºC, and a final melt step ramp from 60ºC till 95ºC rising 1ºC each step) 
on a Rotorgene 6000 real-time cycler (Qiagen). 
 
The raw data was analyzed using the Rotor-gene 6000 Series Software 
1.7. Changes in transcript levels were calculated relative to the housekeeping 
gene according to the following equation: 
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Where E is the amplification efficiency and Ct is the number of PCR-
cycles needed for the signal to exceed a predetermined threshold value. 
 
Glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) was 
incorporated in all qPCR experiments as internal reference gene. Reactions 
lacking reverse transcriptase (-RT) or template were included as controls in all 
experiments and no amplification above background levels was observed for 
these controls. Non-template controls were included for each gene in each run 
and no amplification above background levels was observed. The melting 
temperature and profile of each melting curve was checked to ensure specificity 
of the amplification product.  
 
4.6. CALUX Bioassay 
CALUX cells were grown confluent in a 96 well white clear bottom plate 
and exposed overnight in triplicate to TCDD as standard(0 nM, 0.1 nM, 1 nM, 5 
nM and 10 nM TCDD) and non-standard stimulatory compounds (100 µM 
Curcumin, 100 µM β-naphtophlavone, 100 µM Quercetin) for the first study and 
with the Caco-2 supernatants (after Caco-2 monolayer stimulation with 10 µM 
TCDD, 100 µM β-naphtophlavone, 100 µM Quercetin and 6 nM DIM) for the 
second study. Each well contained 100 µL medium with standards and samples 
diluted and dissolved in the medium. Following 24 hours exposure, cells were 
washed twice with 250 µl pre-warmed PBS and lysed in 20 µL lysis reagent 
(Luciferase cell culture lysis 5X reagent, Promega, Madison, WI, USA). After 10 
minutes 100 µL assay buffer  (20 mM Tricine, 1.07 mM  (MgCO3)4Mg(OH)2, 
2.67 mM  MgSO4·7H2O, 0.1 mM EDTA, 33.3 mM DTT, 261 µM Coenzyme A, 
470 µM Luciferin, 530 µM ATP, pH 7.8) was added and luminescence 
measured in a Spectramax M5. Plates were shaken briefly prior to 
measurement. 
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4.7. Electrical resistance measurements in monolayer cell culture 
CaCo-2 cells were cultured on transwell insert filters for 2 weeks in order 
to let cells monolayers reach a density of 2.6·105 cells/cm2 and trans-epithelial 
resistance (TER) was measured using chopsticks. 
 
4.8. Statistical analysis 
Results are presented as the mean ±standard deviation (SD) of 
triplicates. All data were analyzed by a t-test. A value of p < 0.05 was 
considered as statistically significant. All statistical analyses were performed 
using Graphpad Prism software. 
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5. RESULTS AND DISCUSSION 
CYP1A2 assay  
The CYP1A2 Induction/Inhibition assay was the first assay tested for the 
screening of known AhR ligands for its simplicity in the procedure. It was 
performed after 24 and 48 hours stimulation of HepG2 cells with different 
compounds (DIM, curcumin, L-kynurenine, β-naphtophlavone, quercetin, 
resveratrol and TCDD as a positive control and medium as a negative control).  
The differences between the positive (TCDD) and negative (medium) 
control values, despite they are significant, were too small (around 40 RLU) to 
detect subtle changes, as it is known that in the assays based on luminescence 
measurement the differences between controls are in the order of 1000 RLU. 
Furthermore, the variation between duplicates and different assays performed 
was too big to trust the results. Luminescence was measured after 24h and 48h 
stimulation to see what the best point to measure luminescence signal was but 
no significant differences could be observed between the times (Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. CYP1A2 assay results. Values are expressed as the relative light units 
(RLUs) and represent the mean ± SD of triplicate determinations. *p < 0.05 compared to 
medium. 
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qPCR  
Quantitative PCR with mRNA isolated from stimulated HepG2 cells was 
performed as the CYP1A2 assay was not sensible enough to detect differences 
between induced cultures and the negative control.  
All compounds tested (β-naphthoflavone, quercetin, resveratrol, DIM and 
L-kynurenine) induced CYP1A1 expression, which was not due to the solvents 
that the compounds were dissolved in but because of the compounds 
themselves. This results were expected as the product that has the power to 
bind to AhR ligand is the compound and the solvent is only used to dilute the 
compound in order to achieve the appropriate concentration (Figure 7). As it is 
known from literature that α-naphthoflavone has an inhibitory effect on the AhR 
signaling pathway 44, cells were stimulated either with TCDD and TCDD mixed 
with α-naphthoflavone (TCDD+) to confirm the effect of α-naphthoflavone 
inhibition on the CYP1A1 expression. As observed in the graph, the expression 
of TCDD when α-naphthoflavone was added (TCDD+) is significantly lower than 
without (TCDD) which is thus in agreement with our expectations.  
 
Figure 7. qPCR results. Values are expressed as the relative light units (RLUs) and represent 
the mean ± SD of triplicate determinations. *p < 0.05 compared to medium, **p < 0.01 
compared to TCDD. 
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DR-CALUX™ Bioassay  
DR-CALUX Bioassay was performed to evaluate its potential as a 
replacement technique for qPCR, as it is less expensive, quicker and easier to 
handle.   
The clear effect of β-naphtophlavone (β-Nap) on the binding of AhR-
complex to DRE element is also appreciated, as its signal is around 35 times 
higher than the control. Results for quercetin are also statistically significant 
although the signal is just 1.24 times higher compared to the control.  
Moreover, as this assay gave the best results compared to CYP1A2 
Induction/Inhibition assay or QPCR, a comparison between freshly prepared 
compounds and compounds prepared some days before the assay was made 
in order to test the stability of the compounds. Figure 8 shows a progressive 
decline between day 0 and day 7, but the signal is significant in day 0 and day 
5, suggesting that the compounds can be used 5 days after their preparation 
and they will still gave a strong signal.    
 
 
 
Figure 8. DR. CALUX Bioassay results. Values are expressed as the 
relative light units (RLUs) and represent the mean ± SD of triplicate 
determinations. *p < 0.05 compared to medium. 
21 
 
Comparison between the CYP1A2 assay (Figure 6) and the DR.CALUX 
Bioassay (Figure 8) signals suggest that the second one is more reliable. 
Although the two methods measure different phenomena we are interested in 
finding the system with the higher sensibility and precision to evaluate the effect 
of Ahr ligands on cell cultures. So, Dr. CALUX showed better results in terms of 
both parameters, as the RLU is comparable with the values obtained in other 
experiments done with the same assay and not a big deviation in the duplicates 
is appreciated. 
 
Intestinal uptake of AhR-ligand compounds 
Electrical resistance measurements in polarized Caco-2 monolayers 
grown in transwell filter inserts where done in order to test the concentration 
effect of the compounds on epithelial permeability, as higher doses of those 
compounds can kill the cells and brake the monolayer. Thus, it is important to 
check the TER, as it permits to know if the compounds damage the cell 
monolayer, leaving the samples unusable, and adjust the concentration tested.   
 
After culturing Caco-2 cells on filters for 2 weeks to allow monolayer and 
tight junction formation and cell polarization, TER was measured before and 
after the stimulation of the apical (A) or basolateral (B) compartments, for 24 
hours with different compounds. Table  1 shows that none of the Ahr ligands 
increased significantly the permeability of the membrane as the TER values 
were similar to that of the negative control. This means that none of the ligands, 
at the tested concentrations, damaged the monolayer.  These results were as 
expected since the concentration of the compounds used was taken from the 
literature, where non of the concentrations showed epithelial barrier damage.  
 
 
 
 
22 
 
 TER (Ω) 
 Before stimulation 24h stimulation 
Medium (A) 1,70 5,51 
Quercetin (A) 1,46 5,45 
β-Naphthoflavone (A) 1,32 5,14 
DIM (A) 1,38 4,91 
TCDD (A) 1,32 4,20 
TCDD (B) 1,33 5,16 
Table  1. TER measurements. 
 
Once it was known that the monolayers were not damaged, so they could 
be used in further experiments, we wanted to know whether the cells are able to 
take compounds from the basolateral side (which represents the lamina propria, 
or the serosal side) and/or if they can do it from the apical side (luminal side). 
Therefore, cells were stimulated apically (A) or basolaterally (B) with TCDD 
(used as positive control) and the apical supernatants were tested with the 
CALUX assay. Figure 9 shows that the signal from the cells stimulated 
basolaterally is the same as that of the control medium, confirming that the 
compounds are not able to be transported from the lumen. The apical 
stimulation is much stronger, as it doubles the control value, suggesting that 
Caco-2 cells use the compounds, but the basolateral compartment of the apical 
stimulated sample (A) should be tested to know if transport from the lumen 
exists 
. 
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Thus, to know if the compounds pass through the cell layer, so from the 
apical compartment to the basolateral compartment, cells were stimulated 
apically with different compounds and the apical (A) and basolateral (B) 
supernatants were tested with the CALUX assay. Figure 10 shows more signal 
for all compounds in the apical supernatants compared to the basolateral ones, 
suggesting that the compounds tested pass through the cell layer, as signal in 
the supernatant of both compartments is seen. With DIM, signal is higher in the 
basolateral side than in the apical one, and this could be due to a faster uptake 
of this component than the others or as a result of a more active transport.  
For now, whether the compounds are taken up by the Caco-2 cells and 
secreted (so transcellular transport from apical to basolateral) or the 
compounds go paracelullar cannot be confirmed. Furthermore, other assays are 
needed to learn whether the compounds are converted by the cells.  
 
Figure 9. CALUX Bioassay results from apical supernatants of polarized 
Caco-2 cells after apical (A) and basolateral (B) stimulation with TCDD. 
Values are expressed as the relative light units (RLUs) and represent the 
mean ± SD of triplicate determinations. *p < 0.05 compared to medium. 
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Figure 10. CALUX Bioassay results from apical (A) and basolateral (B) supernatants of 
polarized Caco-2 cells after apical stimulation with different compounds. Values are expressed 
as the relative light units (RLUs) and represent the mean ± SD of triplicate determinations.       
*p < 0.05 compared to medium. 
 
Finally, once verified that cells takes the compounds from the apical side 
and not from the basolateral one, cells were stimulated apically with different 
compounds and the apical supernatants were tested with the CALUX assay. 
The basolateral supernatants were not tested as the aim of this last experiment 
was to check which compounds significantly signals as AhR ligands. In Figure 
11 it can be seen that β-naphthoflavone and DIM induce the AhR pathway. 
 
 
 
 
 
 
 
 
 
Figure 11. CALUX Bioassay results from apical supernatants of polarized Caco-2 cells after 
apical stimulation with different compounds. Values are expressed as the relative light units 
(RLUs) and represent the mean ± SD of triplicate determinations. *p < 0.05 compared to 
medium. 
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6. CONCLUSIONS 
The results described in this report indicate that DR.CALUX Bioassay 
seems to be the most promising assay to be used in further studies because it 
is quicker, easier to handle and less expensive than qPCR and more 
reproducible than the CYP1A2 Induction/Inhibition assay. Moreover, DR.CALUX 
Bioassay detects the amount of AhR complex bound to the DRE/XRE 
transcription element so it seems to be more specific for the measurement of 
AhR activity, as it is focus on one step of the AhR-pathway. On the contrary, the 
other two assays tested measures the activity of CYP genes, which can also be 
transcribed by other pathways. 
The inclusion of this bioassay will also allow rapid screening and 
detection of both, known and new AhR agonists. Although the induction seen 
was not the one expected based on literature, the signals obtained with β-
naphthoflavone were high enough to think that this compound can potentially 
replace TCDD as a positive control, avoiding in that way the use of toxic 
compounds.  
Finally, it is important to test the half-life of compounds as it was seen 
that they can be used at least 5 days after their preparation, because this will 
enable to use less amount of compounds as they will not have to be prepared 
fresh every day and save money as a counterpart. 
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